Dialytic therapy for irreversible uremia (second of two parts).
D000085:Acetates / Q000009:adverse effects; D000328:Adult; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology; D001201:Ascites / Q000209:etiology; D002318:Cardiovascular Diseases / Q000150:complications; D004285:Dogs; D006464:Hemoperfusion; D006509:Hepatitis B / Q000209:etiology; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D010530:Peritoneal Dialysis; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods; D013997:Time Factors; D014462:Ultrafiltration; D014511:Uremia / Q000628:therapy*
D000085:Acetates